Dalian BIO-CHEM Company Limited (SHA:603360)
China · Delayed Price · Currency is CNY 13.03
-0.26 (-1.96%)
Sep 4, 2026, 3:00 PM CST
Dalian BIO-CHEM Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 164.82 | 209.77 | 391.76 | 328.38 | 402.57 | 250.49 |
Depreciation & Amortization | 116.65 | 98.17 | 69.72 | 64.04 | 71.01 | 48.22 |
Other Amortization | 7.66 | 7.04 | 0.4 | - | 0.51 | 1.1 |
Loss (Gain) From Sale of Assets | -0.22 | -0.17 | - | - | -0.07 | - |
Asset Writedown & Restructuring Costs | 3.88 | 0.06 | 0.26 | 0.11 | 0.26 | 0.97 |
Loss (Gain) From Sale of Investments | 0.94 | -0.4 | -68.81 | -0.35 | 7.57 | -0.59 |
Provision & Write-off of Bad Debts | -7.24 | -7.24 | 7.24 | -1.43 | 0.83 | 4.1 |
Other Operating Activities | 143.05 | 126.12 | 23.57 | 17.11 | 0.8 | 11.66 |
Change in Accounts Receivable | -184.41 | 241.76 | -263.47 | -9.48 | 43.07 | -120.15 |
Change in Inventory | 10.72 | -120.47 | -48.82 | -25.9 | 6.58 | -81.45 |
Change in Accounts Payable | 223.94 | -4.25 | 47.9 | 6.71 | -73.08 | 1.29 |
Change in Other Net Operating Assets | -1.93 | 2.08 | 0.13 | 15.47 | 8.47 | - |
Operating Cash Flow | 480.62 | 546.69 | 162.98 | 389.69 | 479.9 | 142.03 |
Operating Cash Flow Growth | 381.56% | 235.44% | -58.18% | -18.80% | 237.90% | -32.57% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -63.65 | -36.67 | -74.91 | -67.35 | -134.28 | -191.61 |
Sale of Property, Plant & Equipment | 0.28 | 0.3 | 0.08 | 0.1 | 0 | 0.02 |
Divestitures | - | - | 31.03 | - | 12.25 | - |
Investment in Securities | 47.2 | -153.2 | - | -60 | - | 140 |
Other Investing Activities | 148.39 | 147.76 | 158.17 | 0.33 | -2.57 | 1.19 |
Investing Cash Flow | 132.22 | -41.81 | 114.36 | -126.92 | -124.61 | -50.4 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 99 | 398.49 |
Long-Term Debt Issued | - | 1,314 | 355 | 149.97 | - | - |
Total Debt Issued | 867.79 | 1,314 | 355 | 149.97 | 99 | 398.49 |
Short-Term Debt Repaid | - | - | - | - | -337.99 | -261.28 |
Long-Term Debt Repaid | - | -590 | -270.9 | -129.43 | - | - |
Total Debt Repaid | -590.05 | -590 | -270.9 | -129.43 | -337.99 | -261.28 |
Net Debt Issued (Repaid) | 277.74 | 723.85 | 84.1 | 20.54 | -238.99 | 137.2 |
Issuance of Common Stock | 99.98 | 2.98 | - | 27.77 | 3.75 | 36.92 |
Repurchase of Common Stock | -497.02 | -400.02 | - | - | - | -45.11 |
Common Dividends Paid | -33.54 | -331.55 | -223.62 | -206.86 | -6.5 | -159.02 |
Other Financing Activities | -56.52 | -7.62 | 49.36 | -29.6 | 70.87 | -28.65 |
Financing Cash Flow | -209.37 | -12.36 | -90.17 | -188.16 | -170.86 | -58.66 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -7.71 | -1.49 | 7.69 | 3.4 | -0.2 | -0.53 |
Net Cash Flow | 395.76 | 491.04 | 194.86 | 78.01 | 184.23 | 32.44 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 416.97 | 510.03 | 88.07 | 322.33 | 345.62 | -49.58 |
Free Cash Flow Growth | 1697.21% | 479.14% | -72.68% | -6.74% | - | - |
Free Cash Flow Margin | 27.54% | 29.59% | 6.93% | 30.25% | 27.50% | -4.93% |
Free Cash Flow Per Share | 0.64 | 0.73 | 0.13 | 0.46 | 0.50 | -0.07 |
Levered Free Cash Flow | 401.92 | 433.09 | -386.32 | 217.25 | -64.01 | -15.74 |
Unlevered Free Cash Flow | 408.48 | 452.01 | -382.13 | 219.7 | -61.69 | -8.39 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 0.98 |
Cash Income Tax Paid | 20.48 | 58.41 | 61.44 | 36.41 | 44.77 | 37.56 |
Change in Working Capital | 51.07 | 113.33 | -261.17 | -18.18 | -3.56 | -173.93 |